PepGuard vs Mamenza
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
PepGuard compared with Mamenza
| Detail | 
PepGuard | 
Mamenza |
|---|
| What it does | AI-powered peptide safety analysis against published evidence
| Calculate your ovulation, fertile window and next period day-by-day using the medically standardized 14-day luteal phase method.
|
|---|
| Stage | Not given
| Not given
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | Not given
| NL
|
|---|
| Pricing model | Paid
| Free
|
|---|
| Pricing | Starter: $15/mo (100 checks/month, 1 stack). Pro: $19/mo (125 checks/month, 3 stacks, stack interaction analysis, PDF export). Clinic: $25/mo (165 checks/month, 10 stacks, stack interaction analysis, PDF export, priority support). Weekly and monthly billing cycles available.
| Not given
|
|---|
| Key features | - AI-powered safety scoring weighted by study design and sample size
- Regulatory status lookup for US FDA approvals and investigational status
- Peptide stack builder with dosing calendar and adherence tracking
- Stack interaction analysis across multiple compounds
- PDF export of full reports
- Mobile app label scanning capability
- Real-time evidence retrieval from three primary sources
- Risk flag identification for specific peptides
| - Calculates ovulation date based on cycle length and luteal phase method
- Predicts 6-day fertile window
- Forecasts next period date
- Displays 3-month cycle preview
- Customizable cycle length input
- Identifies highest fertility days
- Guidance for irregular cycles
|
|---|
| What makes it different | - No vendor spin or cherry-picked studies in reports
- Evidence scored by research quality, not advertising budget
- Covers 29 peptide compounds with detailed analysis
- Results delivered in seconds with full source traceability
- No medical advice: pure research summarization tool
| - Uses medically standardized 14-day luteal phase method per Wilcox 1995 and ASRM 2023
- Completely free to use
- Part of comprehensive pregnancy and family planning platform
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | Not checked yet ● no change since last check | 36 ▲ +1 (up) since last check |
|---|
| Trust Flow (Majestic) | 0 | 28 |
|---|
| Citation Flow (Majestic) | 10 | 29 |
|---|
| Referring domains (Majestic) | 11 | 119 |
|---|
4 details filled in for both companies.
More alternatives to PepGuard More alternatives to Mamenza